|
pharmaceuticals are placed and returned to a single collection | location.__The prepaid mailing envelopes must be made available to | the public at various locations, including, but not limited to, | pharmacies, physicians' offices and post offices.__The agency may | randomly assess the toxicity of materials received under the | program as long as the assessment results do not identify the | patient, person who mailed the material, prescriber or pharmacy. |
|
| | 4.__Disposal of pharmaceuticals.__The agency shall ensure that | only agency officers handle the unused pharmaceuticals received | pursuant to subsection 3.__The unused pharmaceuticals must be | disposed of by the agency in a manner that is designed to be | effective, secure and in compliance with local, state and federal | environmental requirements, including the federal Resource | Conservation and Recovery Act of 1976, as amended. |
|
| | 5.__Unused Pharmaceutical Disposal Program Fund; funding.__The | Unused Pharmaceutical Disposal Program Fund, referred to in this | chapter as "the fund," is established within the agency to be | used by the director of the agency to fund or assist in funding | the program.__Any balance in the fund does not lapse but is | carried forward to be expended for the same purposes in | succeeding fiscal years.__The fund must be deposited with and | maintained and administered by the agency.__The agency may accept | funds into the fund from any non-General Fund, nonpublic fund | source, including grants or contributions of money or other | things of value, that it determines necessary to carry out the | purposes of this chapter.__Money received by the agency to | establish and maintain the program must be used for the expenses | of administering this chapter. |
|
| | 6.__Rulemaking.__The agency shall adopt rules to carry out the | purposes of this chapter.__Rules adopted pursuant to this | subsection are routine technical rules as defined in Title 5, | chapter 375, subchapter 2-A. |
|
| | Sec. 2. Maine Drug Return Implementation Group. The Maine Drug Return | Implementation Group, referred to in this section as "the | implementation group," is established to work on implementation | issues for the Unused Pharmaceutical Disposal Program, | established in the Maine Revised Statutes, Title 22, chapter 604, | referred to in this section as "the program." |
|
| | 1. Issues. The implementation group shall study the | following issues and make recommendations for implementation of | the program in a manner that addresses the issues, safeguards the | public health and environment and meets the requirements of | local, state and federal law, rule and regulation: |
|
|